Royal Bank of Canada’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-220,582
| Closed | -$18.8M | – | 7514 |
|
|
2020
Q3 | $18.8M | Buy |
220,582
+117,308
| +114% | +$5.93M | 0.01% | 1126 |
|
|
2020
Q2 | $3.66M | Buy |
103,274
+3,178
| +3% | +$92.9K | ﹤0.01% | 2158 |
|
|
2020
Q1 | $1.35M | Sell |
100,096
-8,180
| -8% | -$138K | ﹤0.01% | 2803 |
|
|
2019
Q4 | $2.29M | Buy |
108,276
+31,033
| +40% | +$547K | ﹤0.01% | 2777 |
|
|
2019
Q3 | $1.02M | Sell |
77,243
-965
| -1% | -$14.2K | ﹤0.01% | 3332 |
|
|
2019
Q2 | $1.08M | Buy |
78,208
+4,737
| +6% | +$71.3K | ﹤0.01% | 3236 |
|
|
2019
Q1 | $1.41M | Buy |
73,471
+68,143
| +1,279% | +$1.1M | ﹤0.01% | 2933 |
|
|
2018
Q4 | $76K | Sell |
5,328
-217,138
| -98% | -$4.31M | ﹤0.01% | 4875 |
|
|
2018
Q3 | $4.63M | Sell |
222,466
-54,940
| -20% | -$1.3M | ﹤0.01% | 2164 |
|
|
2018
Q2 | $6.57M | Buy |
277,406
+121,080
| +77% | +$2.43M | ﹤0.01% | 1828 |
|
|
2018
Q1 | $2.28M | Buy |
156,326
+152,941
| +4,518% | +$2.5M | ﹤0.01% | 2588 |
|
|
2017
Q4 | $55K | Sell |
3,385
-9,926
| -75% | -$117K | ﹤0.01% | 5135 |
|
|
2017
Q3 | $186K | Buy |
13,311
+5,155
| +63% | +$51.4K | ﹤0.01% | 4569 |
|
|
2017
Q2 | $72K | Sell |
8,156
-1,643
| -17% | -$11.5K | ﹤0.01% | 4946 |
|
|
2017
Q1 | $63K | Sell |
9,799
-2,587
| -21% | -$13.1K | ﹤0.01% | 5027 |
|
|
2016
Q4 | $45K | Buy |
12,386
+4,880
| +65% | +$14.4K | ﹤0.01% | 5323 |
|
|
2016
Q3 | $24K | Sell |
7,506
-101
| -1% | -$282 | ﹤0.01% | 5486 |
|
|
2016
Q2 | $17K | Buy |
7,607
+266
| +4% | +$889 | ﹤0.01% | 5574 |
|
|
2016
Q1 | $19K | Sell |
7,341
-4,253
| -37% | -$9.56K | ﹤0.01% | 5514 |
|
|
2015
Q4 | $36K | Sell |
11,594
-15,432
| -57% | -$43.1K | ﹤0.01% | 5477 |
|
|
2015
Q3 | $46K | Sell |
27,026
-22,975
| -46% | -$58.6K | ﹤0.01% | 5177 |
|
|
2015
Q2 | $203K | Buy |
50,001
+5,436
| +12% | +$22.2K | ﹤0.01% | 4349 |
|
|
2015
Q1 | $171K | Buy |
44,565
+33,459
| +301% | +$146K | ﹤0.01% | 4320 |
|
|
2014
Q4 | $53K | Buy |
11,106
+7,500
| +208% | +$29.6K | ﹤0.01% | 5034 |
|
|
2014
Q3 | $13K | Buy |
3,606
+2,500
| +226% | +$8.45K | ﹤0.01% | 5410 |
|
|
2014
Q2 | $4K | Buy |
+1,106
| New | +$4.06K | ﹤0.01% | 5627 |
|
|
2013
Q4 | – | Sell |
-1,079
| Closed | -$7K | – | 6249 |
|
|
2013
Q3 | $7K | Buy |
1,079
+1,039
| +2,598% | +$5.98K | ﹤0.01% | 5545 |
|
|
2013
Q2 | $0 | Buy |
+40
| New | +$131 | ﹤0.01% | 5866 |
|
Royal Bank of Canada's IMMU Position: Q4 2020 in Review
Royal Bank of Canada sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 220,582 shares — an estimated $18.8M sold.
Royal Bank of Canada first reported a position in IMMU in Q2 2013 and held it in 28 quarters. The position peaked at $18.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Royal Bank of Canada reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Royal Bank of Canada sold 220,582 Immunomedics Inc shares in Q4 2020, an estimated $18.8M.
- Royal Bank of Canada first reported a position in Immunomedics Inc in Q2 2013 and held it in 28 quarters.
- Royal Bank of Canada's Immunomedics Inc position peaked at $18.8M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.